The BIO CConference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.
Pharmidex will be attending “The 17th Annual BIO CEO & Investor Conference”
The BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.
Those attending the conference will have the opportunity to explore a broad variety of industry related investment opportunities. Additionally delegates would have a chance to network with institutional investors, industry analysts & senior biotechnology executives.
Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities. BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.
The event will be taking place on the 9-10 February 2015, New York City, NY, USA.
